Sonia Lluva-Castillo
Av. Complutense S/n
Madrid, MD 28040, Spain
Madrid, MD 28040, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Silver-selenium hybrid nanocomposite with combined cytotoxic and metabolic reprogramming effects in triple-negative breast cancer.
Journal: Colloids and surfaces. B, Biointerfaces
Published: December 10, 2025
A third-generation rhodium-based nanophotosensitizer for precision photodynamic cancer therapy.
Journal: Journal of colloid and interface science
Published: November 21, 2025
A RAC1 SUMOylation switch governs breast cancer metastasis.
Journal: Signal transduction and targeted therapy
Published: November 05, 2025
Cannabinoid CB2 receptor drives trastuzumab resistance and predicts durable anti-HER2 response.
Journal: Oncogene
Published: August 06, 2025
Advancing rhodium nanoparticle-based photodynamic cancer therapy: quantitative proteomics and in vivo assessment reveal mechanisms targeting tumor metabolism, progression and drug resistance.
Journal: Journal of materials chemistry. B
Published: October 25, 2024
SUMOylation regulates the aggressiveness of breast cancer-associated fibroblasts.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: October 07, 2024
Cabergoline as a Novel Strategy for Post-Pregnancy Breast Cancer Prevention in Mice and Human.
Journal: Research square
Published: February 26, 2024
Mechanistic insights into the antitumoral potential and in vivo antiproliferative efficacy of a silver-based core@shell nanosystem.
Journal: International journal of pharmaceutics
Published: January 08, 2024
The PI3K-AKT-mTOR axis persists as a therapeutic dependency in KRASG12D-driven non-small cell lung cancer.
Journal: Molecular cancer
Published: November 03, 2023
NCAPH drives breast cancer progression and identifies a gene signature that predicts luminal a tumour recurrence.
Journal: Clinical and translational medicine
Published: October 21, 2023
Last Updated: 09/26/2026